Global Aortic Stent Graft Patent Landscape Analysis 2024: By Product Type: Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft; Key Player Profiles

Global Aortic Stent Graft Market Size

The aortic stent graft market was valued at USD 3.11 billion in 2023. It is expected to grow at a CAGR of 5.3% during the forecast period of 2024-2032 and attain a market value of USD 4.95 billion in 2032.

There has been a significant increase in number of patent applications associated with aortic stent grafts, driven by the advent of new and technically advanced product launches. The launch of such devices is prompting healthcare institutions to secure their technologies and maintain their market presence.

Patent Landscape Report Coverage

The Global Aortic Stent Graft Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for global aortic stent graft include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within aortic stent graft technologies.

A thoracic aortic stent graft is used to treat thoracic aortic dissections and aneurysms. It consists of a fabric tube that is inserted into the thoracic aorta using minimally invasive techniques and is supported by a metal frame. Instead of open surgical repair, which can shorten recovery times and worsen patient outcomes, stent-grafts strengthen and seal off compromised or diseased sections of the aorta.

Global Aortic Stent Graft Patent Outlook

• The incidence of aortic diseases like aneurysms and dissections, which are more common in the geriatric population is on the rise. The aging population's increasing need for efficient and minimally invasive aortic condition management is boosting the number of patent applications.

• Advances in material science have made it possible for stent graft designs to remain flexible and durable, which has improved its conformability to the anatomy of the aorta.

• The inclination towards minimally invasive surgeries, like aortic stent grafts, is also driven by its advantages like less time spent recovering from surgery, fewer complications following the procedure, and lower medical expenses.

What is an Aortic Stent Graft?

An aortic stent graft is used to treat aortic aneurysms and other aortic disorders. Its minimally invasive procedures involve inserting a fabric tube into the aorta, which is held up by a metal mesh framework. When the stent graft is implanted, it strengthens the weak or diseased aortic wall, effectively sealing the aneurysm and rerouting blood flow to stop it from rupturing or expanding further. This method reduces patient complications and recovery times by providing a less invasive substitute for open surgical repair.

The aortic stent graft market continues to evolve as proactive screening initiatives and increased knowledge of aortic diseases aid in early identification and treatment driving the demand for aortic stent grafts. Also, aortic stent graft adoption is facilitated by favorable reimbursement policies for medical devices and minimally invasive procedures increasing the scope of the market.

Aortic Stent Graft Industry Growth Drivers

Rising Preference for Minimally Invasive Procedures is Expected to Boost the Market Growth

Minimally invasive procedures (like aortic stent grafts) can provide shorter hospital stays, lower risks of complications, and faster recovery times than open surgeries. Hence, they are becoming more popular. These procedures are preferred by both patients and healthcare professionals due to their ability to produce positive treatment outcomes with less trauma and faster recovery, which is consistent with the global trend towards less invasive medical interventions.

For instance, Cook Medical introduced Zenith Alpha Thoracic Endovascular Graft for patients treated endovascularly with descending thoracic aortic aneurysms or ulcers with vascular morphology amenable for endovascular repair. Such products support global market expansion and patient acceptance by meeting the growing need for less invasive treatment options. With the increasing acceptance and innovation in technology, there has been an increase in patent grants rising from 590 patents in 2022 to 596 patents in 2023.

Increasing Technological Advancements is Expected to Propel the Aortic Stent Graft Patent Industry

Continuous improvements in materials, structure, and deployment techniques are part of the technological advances in stent graft design, which aim to improve the device's flexibility, durability, and ease of deployment. By enhancing patient outcomes, increasing the applicability of minimally invasive treatments for aortic diseases, and optimizing stent graft performance, these innovations aim to propel market growth and application for patents.

Global Aortic Stent Graft Patent Segmentation

The report provides an in-depth analysis of the patents in this field by the following segmentation:

Breakup by Product Type

• Abdominal Aortic Stent Graft

• Thoracic Aortic Stent Graft

Aortic Stent Graft Patent Segmentation Analysis

The breakup based on product type includes abdominal aortic stent graft and thoracic aortic stent graft. Aortic stent graft track usage and issue alerts, improve patient compliance and treatment efficiency. These developments improve health outcomes and simplify disease management, increasing the appeal to users.

An abdominal aortic stent graft is used in a minimally invasive device working on procedures to treat abdominal aortic aneurysms (AAA). Its design is to reinforce weak or diseased vessel walls by inserting a fabric tube into the abdominal aorta, which is held up by a metal framework. Compared to traditional surgical methods, this approach offers patients shorter recovery times and fewer complications because it avoids the need for open surgery.

Detailed technological data will be provided for all specified segments classified in this report.

Aortic Stent Graft Patent Jurisdiction Analysis 

The United States is one of the leading jurisdictions for aortic stent graft patents, having around 21,500 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.

Holding a significant chunk of the global population, China is another vital jurisdiction and is witnessing rapid growth in patent filings. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications.

Patent Profile of Key Companies

Among the players with aortic stent graft patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Cook Medical Technologies LLC

A leading innovator and producer of medical devices, such as grafts for aortic stents, Cook Medical is a company renowned for its advancements in minimally invasive medical treatments and provides a selection of stent graft products intended to treat aortic dissections and aneurysms. The company's primary goal is to improve patient outcomes by utilizing cutting-edge medical technology and all-inclusive solutions.

Boston Scient Scimed Inc

A renowned company for innovative work in aortic stent grafts and other medical technology. Boston Scientific Scimed Inc., a leader in cutting-edge treatments for peripheral vascular and cardiovascular illnesses, creates stent-grafts, which offer minimally invasive alternatives for treating aortic pathologies, including aneurysms. Their products are designed to provide cutting-edge therapeutic solutions and medical devices that enhance patient outcomes.

Other companies include Edwards Lifesciences Corp, Medtronic Vascular INC, and Advanced Cardiovascular System, among others.

Reasons to Purchase this Report

The Global Aortic Stent Graft Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and also makes it understandable which companies have important patents in this field of Aortic Stent Graft.

• Innovation Insights: The patent analysis reveals new innovations and technologies in aortic stent graft industry.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry.

• Risk Assessment: In technology-intensive fields such as pumps for microfluidic devices, risks of IP infringement are common. Analysing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

• Legal and Regulatory Compliance: Understanding the patent landscape is critical to ensuring compliance with patent laws and regulations. It helps stakeholders navigate license agreements, avoid infringement lawsuits, and effectively use IP assets in a global marketplace.

Key Questions Answered in the Global Aortic Stent Graft Patent Landscape Report

• Who are the key players in the aortic stent graft patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in aortic stent graft patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the aortic stent graft industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in aortic stent graft?
• What are the challenges and opportunities in the aortic stent graft patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in aortic stent grafts?

Related Reports

Global Aortic Valve Replacement Devices Market 

Global Lung Stent Market

Global Vascular Stents Market

Global Coronary Artery Bypass Graft Procedures Market

Global Hemodialysis Vascular Grafts Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.